Toi Y, Kimura Y, Domeki Y, Kawana S, Aiba T, Ono H, et al. Association of low body surface area with dose reduction and/or discontinuation of nintedanib in patients with idiopathic pulmonary fibrosis: a pilot study: BSA and nintedanib reduction/discontinuation. Sarcoidosis Vasc Diffuse Lung Dis [Internet]. 2019 Mar. 11 [cited 2024 Nov. 26];36(1):74-8. Available from: https://mattioli1885journals.com/index.php/sarcoidosis/article/view/7383